| Q36714818 | A closed system supports the developmental competence of human embryos after vitrification : Closed vitrification of human embryos |
| Q47319454 | A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos |
| Q57091905 | A new, simple, automatic vitrification device: preliminary results with murine and bovine oocytes and embryos |
| Q35771733 | A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts. |
| Q37601097 | A randomized controlled trial comparing two vitrification methods versus slow-freezing for cryopreservation of human cleavage stage embryos |
| Q36851770 | A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles |
| Q92799814 | A systematic review of database validation studies among fertility populations |
| Q38501367 | Analysis of global gene expression following mouse blastocyst cryopreservation |
| Q41597145 | Appendix A: Cryotech® Vitrification Thawing |
| Q41597106 | Appendix G: Vitrification of Blastocysts Using VitriBlastTM and ThermoBlastTM: Nidacon |
| Q37214916 | Approaches to improve the diagnosis and management of infertility |
| Q35914179 | Artificial shrinkage of blastocoel using a laser pulse prior to vitrification improves clinical outcome |
| Q36758983 | Artificial shrinkage of blastocysts prior to vitrification improves pregnancy outcome: analysis of 1028 consecutive warming cycles |
| Q48665458 | Assessment of 1,2-propanediol (PrOH) genotoxicity on mouse oocytes by comet assay |
| Q38210367 | Assisted reproductive technology results: why are live-birth percentages so low? |
| Q39597729 | Birth of normal infants after transfer of embryos that were twice vitrified/warmed at cleavage stages: Report of two cases |
| Q41522452 | Blastocyst transfer does not improve cycle outcome as compared to D3 transfer in antagonist cycles with an elevated progesterone level on the day of hCG. |
| Q36341644 | Blastocyst transfer in frozen-thawed cycles |
| Q37832589 | Cancer and fertility: strategies to preserve fertility |
| Q33449183 | Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data |
| Q41601875 | Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study. |
| Q35104492 | Comparing thaw survival, implantation and live birth rates from cryopreserved zygotes, embryos and blastocysts. |
| Q34116080 | Comparison of DNA apoptosis in mouse and human blastocysts after vitrification and slow freezing |
| Q42697462 | Comparison of a 'freeze-all' strategy including GnRH agonist trigger versus a 'fresh transfer' strategy including hCG trigger in assisted reproductive technology (ART): a study protocol for a randomised controlled trial. |
| Q64974443 | Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist. |
| Q41602412 | Comparison of vitrification and conventional freezing for cryopreservation of caprine embryos |
| Q27009361 | Creating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patients |
| Q35723266 | Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population |
| Q55122140 | Cryopreservation in ART and concerns with contamination during cryobanking. |
| Q41598252 | Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. |
| Q61810204 | Day 7 blastocyst euploidy supports routine implementation for cycles using preimplantation genetic testing |
| Q48716040 | Debate in embryo donation: embryo donation or both-gamete donation? |
| Q39037964 | Does GnRH Agonist Triggering Control Painful Symptom Scores During Assisted Reproductive Technology? A Retrospective Study |
| Q42117914 | Effect of day 3 embryo morphometrics and morphokinetics on survival and implantation after slow freezing-thawing and after vitrification-warming: a retrospective cohort study. |
| Q37140349 | Effect of embryo morphology and morphometrics on implantation of vitrified day 3 embryos after warming: a retrospective cohort study. |
| Q34230991 | Effects of cryopreservation on the meiotic spindle, cortical granule distribution and development of rabbit oocytes |
| Q51228454 | Factors related to clinical pregnancy after vitrified-warmed embryo transfer: a retrospective and multivariate logistic regression analysis of 2313 transfer cycles |
| Q36816450 | Female fertility: is it safe to "freeze?" |
| Q41602452 | Forced collapse of the blastocoel cavity improves developmental potential in cryopreserved bovine blastocysts by slow-rate freezing and vitrification |
| Q27000656 | Freeze-all policy: is it time for that? |
| Q47900817 | Frozen embryo transfer: a review on the optimal endometrial preparation and timing. |
| Q47961842 | Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues |
| Q36706315 | Future Directions in Oncofertility and Fertility Preservation: A Report from the 2011 Oncofertility Consortium Conference |
| Q41597264 | GnRh Agonist Treatment Improves Implantation and Pregnancy Rates of Frozen-Thawed Embryos Transfer |
| Q42824958 | High throughput cryopreservation of cells by rapid freezing of sub-μl drops using inkjet printing--cryoprinting |
| Q34247355 | Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction |
| Q92106259 | In Freeze-All Strategy, Cumulative Live Birth Rate (CLBR) Is Increasing According to the Number of Blastocysts Formed in Women <40 Undergoing Intracytoplasmic Sperm Injection (ICSI) |
| Q41603395 | In vitro fertilization and intracytoplasmic sperm injection: current medical aspects |
| Q37878604 | In vitro fertilization: Four decades of reflections and promises |
| Q35767887 | In vitrodevelopment and gene expression of frozen-thawed 8-cell stage mouse embryos following slow freezing or vitrification |
| Q48181887 | Increased live births after day 5 versus day 6 transfers of vitrified-warmed blastocysts |
| Q92692188 | Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle |
| Q92622075 | Increased pregnancy outcome after day 5 versus day 6 transfers of human vitrified-warmed blastocysts |
| Q41603855 | Influence of cell loss after vitrification or slow-freezing on further in vitro development and implantation of human Day 3 embryos |
| Q39568399 | Influence of storage time on vitrified human cleavage-stage embryos froze in open system |
| Q44959986 | Live birth from a frozen–thawed pronuclear stage embryo almost 20 years after its cryopreservation |
| Q37363032 | Long Cut Straw Provides Stable the Rates of Survival, Pregnancy and Live Birth for Vitrification of Human Blasotcysts |
| Q48642805 | Molecular strategies for pre-implantation genetic diagnosis of single gene and chromosomal disorders |
| Q39777474 | Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer |
| Q41606738 | Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer |
| Q35236598 | Neonatal outcomes after the implantation of human embryos vitrified using a closed-system device |
| Q34477597 | Neonatal outcomes after the transfer of vitrified blastocysts: closed versus open vitrification system |
| Q94389970 | New Promising Strategies in Oncofertility |
| Q35591046 | New algorithm for OHSS prevention |
| Q28077375 | Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance |
| Q41606787 | Outcome of embryo vitrification compared to slow freezing process at early cleavage stages. Report of the first French birth |
| Q36295584 | Outcomes of day 3 embryo transfer with vitrification using Cryoleaf: a 3-year follow-up study |
| Q57093218 | Predictive value of initial serum human chorionic gonadotropin levels for pregnancies after single fresh and frozen blastocyst transfer |
| Q41599204 | Pregnancy outcomes of blastocysts cultured overnight after thawing |
| Q33888288 | Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts |
| Q41597864 | Prognostic factors for patients undergoing vitrified-warmed human embryo transfer cycles: a retrospective cohort study. |
| Q38661052 | Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers |
| Q57091133 | Rapid freezing versus Cryotop vitrification of mouse two-cell embryos |
| Q43476409 | Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction |
| Q33591887 | Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer |
| Q38914169 | Safe and effective cryopreservation methods for long-term storage of human-amniotic-fluid-derived stem cells. |
| Q39740583 | Shortened equilibration time can compromise clinical outcomes in human embryo vitrification |
| Q35042077 | Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3? |
| Q48290131 | Should intrauterine human chorionic gonadotropin infusions ever be used prior to embryo transfer? |
| Q35689045 | Single vitrified blastocyst transfer maximizes liveborn children per embryo while minimizing preterm birth |
| Q24203957 | Slow freeze versus vitrification for embryo cryopreservation |
| Q37214117 | Slow freezing and vitrification of mouse morula and early blastocysts |
| Q36127684 | Slow freezing should not be totally substituted by vitrification when applied to day 3 embryo cryopreservation: an analysis of 5613 frozen cycles |
| Q91102617 | Study of metabolic activity of human embryos focused on amino acids by capillary electrophoresis with light-emitting diode-induced fluorescence detection |
| Q53625016 | Successful use of the Cryolock device for cryopreservation of scarce human ejaculate and testicular spermatozoa |
| Q34962742 | Survival, re-expansion and cell survival of human blastocysts following vitrification and warming using two vitrification systems |
| Q90176453 | The Future of Cryopreservation in Assisted Reproductive Technologies |
| Q24596913 | The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer Patients |
| Q36670066 | The freezing method of cleavage stage embryos has no impact on the weight of the newborns |
| Q90716490 | The growth and development conditions in mouse offspring derived from ovarian tissue cryopreservation and orthotopic transplantation |
| Q36863270 | The new Rapid-i carrier is an effective system for human embryo vitrification at both the blastocyst and cleavage stage |
| Q33845304 | The worldwide frozen embryo reservoir: methodologies to achieve optimal results |
| Q90320825 | Tolerance of lamb and mouse oocytes to cryoprotectants during vitrification |
| Q26747035 | Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair |
| Q37662542 | Vitrification in assisted reproduction: myths, mistakes, disbeliefs and confusion |
| Q37214097 | Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming |
| Q41600629 | Vitrification of cleavage stage day 3 embryos results in higher live birth rates than conventional slow freezing: a RCT. |
| Q35550931 | Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison with vitrification of day 2 cleavage-stage embryos |
| Q38554687 | Vitrification of human blastocysts previously cryopreserved by slow controlled-rate freezing at the cleavage stage |
| Q38339544 | Vitrification of mouse embryo-derived ICM cells: a tool for preserving embryonic stem cell potential? |
| Q33563498 | Vitrification of mouse embryos at 2-cell, 4-cell and 8-cell stages by cryotop method |
| Q37313047 | Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos |
| Q40837712 | What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? A randomized controlled trial. |